Multicentre, Open Label Study to Assess the Tolerability of P-3058 Nail Solution in Paediatric Patients Affected by Mild-to-moderate Onychomycosis
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2018
Price : $35 *
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors Polichem
- 11 Sep 2017 Status changed from active, no longer recruiting to completed.
- 08 Sep 2017 Trial has been completed in Latvia (End date: 2017-08-02).
- 29 Mar 2017 Planned End Date changed from 1 Apr 2017 to 1 Sep 2017.